UK Mice Model Market (2025-2030)
The UK Mice Model Market was valued at $86.2 Million in 2025 and projected to reach to $143.1 Million by 2030, representing a compound annual growth rate of 10.7%. The UK mice model market is positioned for sustained growth through 2030, supported by the nation's strong pharmaceutical and biotechnology ecosystem.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
UK Mice Model Market Trends and Insights
- The UK's robust pharmaceutical and biotechnology research infrastructure drives demand for preclinical models, with the UK hosting world-leading academic institutions and contract research organizations that rely heavily on mice models for drug development and safety testing.
- This growth trajectory reflects the UK's commitment to advancing life sciences research and maintaining its competitive position in global drug discovery. Key drivers of the UK mice model market include increased R&D spending by pharmaceutical companies, expansion of personalized medicine initiatives, and growing adoption of genetically modified mouse strains for disease modeling.
- The UK's regulatory environment and access to specialized breeding facilities support sustained market expansion through 2030.
- Investment in genomics and precision medicine research further accelerates demand for sophisticated mouse models across academic and commercial sectors..
Key Market Statistics
- CAGR (2025-2030) 10.7% CAGR
- Market Size, 2025 ~USD 86.2 Million
- Forecast, 2030 ~USD 143.1 Million
- Country UK
UK Mice Model Market Overview
Market Valuation :
The UK mice model market is valued at £86.2 million in 2025, with strong growth trajectory driven by increasing investment in pharmaceutical R&D and preclinical research across the nation.
Robust Research Infrastructure :
The UK hosts world-leading academic institutions and contract research organizations including the Francis Crick Institute, Wellcome Sanger Institute, and numerous CROs that heavily depend on mice models for drug development.
Strong CAGR Performance :
The UK market is projected to grow at 10.7% CAGR from 2025 to 2030, outpacing the global average of 10%, reflecting the region's commitment to biomedical innovation and research excellence.
Forecast Growth :
Market size is expected to reach £143.1 million by 2030, driven by increased adoption of genetically modified mice models, rising regulatory requirements, and expansion of biotechnology sector investments.
UK Mice Model Market Dynamics
- Continued government funding for life sciences research, coupled with the UK's post-Brexit focus on establishing itself as a global research hub, will drive demand for advanced preclinical models.
- Academic collaborations and CRO expansion are expected to accelerate market penetration. Key growth drivers include increasing complexity of drug development pipelines, rising adoption of personalized medicine approaches, and stringent regulatory requirements mandating comprehensive preclinical testing.
- The UK's commitment to the Life Sciences Vision and investment in research infrastructure will further bolster market expansion, positioning the country as a leading center for mice model research and development..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- The UK mice model market is valued at £86.2M in 2025 and will reach £143.1M by 2030, growing at 10.7% CAGR.
- The UK's leading pharmaceutical and biotech sectors drive strong demand for preclinical mouse models in drug development.
- Genetically modified and disease-specific mouse strains are increasingly adopted across UK research institutions and CROs.
- The UK's regulatory framework and specialized breeding infrastructure support sustained market growth through 2030.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area, End User |
UK Mice Model Market Report Segmentation
6 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
By End User
- Academic & Research Institutes
- Contract Research Organizations (Cros) & Contract Development And Manufacturing Organizations (Cdmos)
- Pharmaceutical & Biotechnology Companies
UK: MICE MODEL TYPE MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 18.6 | 20.3 | 22.5 | 25 | 27.5 | 30 | 32.6 | 35.2 | 9.4 |
| CROS & CDMOS | 9.8 | 10.8 | 12 | 13.4 | 14.8 | 16.2 | 17.7 | 19.2 | 10 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 23.7 | 26.2 | 29.3 | 33 | 36.7 | 40.5 | 44.5 | 48.6 | 10.6 |
| TOTAL | 52 | 57.3 | 63.8 | 71.3 | 79 | 86.8 | 94.8 | 103.1 | 10.1 |
Target Audience
- Pharmaceutical Companies : UK-based and international pharma firms need market data to optimize preclinical research budgets, identify CRO partnerships, and plan drug development timelines aligned with UK regulatory pathways.
- Contract Research Organizations : CROs operating in the UK require competitive intelligence on market sizing, growth trends, and customer demand patterns to inform service expansion, pricing strategies, and facility investments.
- Academic & Research Institutions : UK universities and research institutes need market insights to justify funding applications, benchmark their research capabilities, and identify collaboration opportunities with commercial partners.
- Biotech & Life Sciences Investors : Investment firms and venture capitalists require detailed UK market analysis to evaluate investment opportunities, assess portfolio company growth potential, and identify emerging market trends.
- Suppliers & Equipment Manufacturers : Vendors of laboratory equipment, breeding facilities, and research services need UK-specific demand forecasts to guide product development, sales strategies, and market penetration planning.
Key Companies in the UK Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Reasons to Buy this Report
- UK-Specific Market Intelligence : Gain detailed insights into the UK mice model market dynamics, including regional demand patterns, regulatory landscape, and competitive positioning specific to British pharmaceutical and biotech sectors.
- Growth Opportunity Identification : Identify high-potential segments within the UK market growing at 10.7% CAGR, enabling strategic investment decisions and market entry planning for suppliers and service providers.
- Competitive Landscape Analysis : Understand the competitive positioning of UK-based CROs, academic institutions, and suppliers, including market share distribution and strategic partnerships driving innovation in preclinical research.
- Regulatory & Infrastructure Insights : Access comprehensive data on UK regulatory requirements, research infrastructure capabilities, and institutional demand patterns that shape procurement decisions and business development strategies.
- Forecast-Driven Planning : Leverage detailed 2025-2030 projections to forecast revenue potential, plan capacity expansion, and align product development with anticipated market growth in the UK life sciences sector.
Frequently asked questions
What is the current size of the UK mice model market?
The UK mice model market is valued at £86.2 million in 2025 and is expected to grow to £143.1 million by 2030.
What is the growth rate of the UK mice model market?
The UK mice model market is projected to grow at a compound annual growth rate (CAGR) of 10.7% from 2025 to 2030.
What drives demand for mice models in the UK?
The UK's strong pharmaceutical and biotechnology research sectors, increased R&D investment, and adoption of personalized medicine drive demand for mice models in preclinical drug development and safety testing.
Which sectors in the UK use mice models most?
The UK's pharmaceutical companies, contract research organizations (CROs), and academic research institutions are the primary users of mice models for drug discovery, development, and disease research.
How does the UK mice model market compare to global trends?
The UK mice model market grows at 10.7% CAGR, slightly outpacing the global market CAGR of 10%, reflecting the UK's strong life sciences research ecosystem and investment in precision medicine.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
- Rest Of Latin America Mice Model Market
- Ksa Mice Model Market
- Other GCC Countries Mice Model Market
- UAE Mice Model Market
- GCC Countries Mice Model Market
- Rest Of The Middle East Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report